Mothers and fathers with schizophrenia: Treatment and quality of life

Introduction Schizophrenia is a chronic disease that deteriorates the functionality of patients, especially when raising family and caring for children. We are interested in analyzing characteristics mothers fathers diagnosed with schizophrenia their degree global activity switching from oral treatments to injectable treatments. Objectives 1 To evaluate quality life functional level treated quarterly paliperidone palmitate. 2. compare treatment long-acting injectables. Methods Participants were 3 fathers, 33-40 years old, diagnosis monotherapy who changed monthly palmitate LD IM (525 mg/every 12 weeks). Retrospective data collection. QLS scale. Results Six patients included, caregivers child (80%), 2 children (20%) met inclusion criteria completed questionnaires. After its application correction by means non-parametric tests (N<30). During treatment, scores observed questionnaire of: intrapsychic functions mean 34.2, interpersonal relationships 19, instrumental role 8, daily activities 8. months intramuscular (injectable every weeks ) obtained: 36, 23, 15, 11. A better functioning was categories activities. As well as referred adherence treatment. Conclusions In our experience, Paliperidone Palmitate associated perception parents increases administration facilities planning lives. Disclosure Interest None Declared